Surveillance Systemic Imaging After Curative Intent for Breast Cancer: A Double Standard?
H
Humaid O. Al-Shamsi
N
Nadia Abdelwahed
(Humaid O. Al-Shamsi, MD, FRCPC Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates, Emirates Oncology Society, Dubai, United Arab Emirates, Gulf Medical University, Ajman, United Arab Emirates, Gulf Cancer Society, Alsafa, Kuwait, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates and College of Medicine, Ras Al Khaimah Medical and Health Sciences University, Al Juwais, United Arab Emirates, Nadia Abdelwahed, MD Burjeel Cancer Institute, Burjeel...)
K
Kefah Mokbel
(London Breast Institute, London, United Kingdom)
Article Details
Journal
Journal of Clinical Oncology
Volume / Issue
Vol. 43, Issue 1
Published
January 01, 2025
Pages
109-111
ISSN
0732-183X
Publisher
Lippincott Williams & Wilkins
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
ISSN: 0732-183X Health Sciences
Authors (3)
H
Humaid O. Al-Shamsi
N
Nadia Abdelwahed
Humaid O. Al-Shamsi, MD, FRCPC Burjeel Cancer Institute, Burjeel Medical City, Abu Dhabi, United Arab Emirates, Emirates Oncology Society, Dubai, United Arab Emirates, Gulf Medical University, Ajman, United Arab Emirates, Gulf Cancer Society, Alsafa, Kuwait, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates and College of Medicine, Ras Al Khaimah Medical and Health Sciences University, Al Juwais, United Arab Emirates, Nadia Abdelwahed, MD Burjeel Cancer Institute, Burjeel...
K
Kefah Mokbel
London Breast Institute, London, United Kingdom
Related Articles from this Journal
Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Ismaela Anna Vascotto, Filippo Antonica et al.
Aug 2026
10.1200/jco-26-00658
Allogeneic CD70-Targeted Chimeric Antigen Receptor T-Cell Therapy for Advanced Renal Cell Carcinoma: Results From the Phase I TRAVERSE Trial
Samer A. Srour, Jad Chahoud et al.
Aug 2026
10.1200/jco-26-00388
Adjuvant Carboplatin for Early-Stage, Triple-Negative Breast Cancer: Taxane and Patient Selection
Risako Komata, Kenju Ando et al.
Aug 2026
10.1200/jco-26-00140
Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE)
Ghayas C. Issa, Branko Cuglievan et al.
Aug 2026
10.1200/jco-26-01743
Reply to: Prostate-Specific Membrane Antigen Positron Emission Tomography and Radiometabolic Therapies in Metastatic Castration-Resistant Prostate Cancer
Irbaz Bin Riaz, R. Bryan Rumble et al.
Aug 2026
10.1200/jco-26-01001